Liver transplant breakthrough? albumin may shield kidneys

NCT ID NCT06535945

Recruiting now Disease control Sponsor: Rennes University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether giving extra albumin (a protein in the blood) after a liver transplant can prevent acute kidney injury. About 400 adult liver transplant recipients will be split into two groups: one gets albumin to keep levels above 30 g/L for five days, the other only gets it if levels drop very low. The goal is to see if the extra albumin reduces kidney damage by day seven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic liver failure acute kidney injury prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE KIDNEY INJURY LIVER TRANSPLANTATION

Contacts and locations

Locations

01_CHU de Rennes Hôpital Pontchaillou
RECRUITING

Rennes, 35000, France
02_CHU de Bordeaux - Hôpital Haut Leveque
RECRUITING

Pessac, 33604, France
03_APHP Hôpital Beaujon
RECRUITING

Clichy, 92110, France
04_CHU de Lille Hôpital Huriez
RECRUITING

Lille, 59000, France
05_HCL Hôpital de la Croix Rousse
RECRUITING

Lyon, 69004, France
06_CHU de Montpellier Hôpital St Eloi
RECRUITING

Montpellier, 34295, France
08_CHRU de Tours Hôpital Trousseau
RECRUITING

Chambray-lès-Tours, 37170, France
09_APHP Hôpital Paul Brousse
RECRUITING

Villejuif, 94804, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.